EUVIMEDEUVIMED entdecken
Systematische Übersicht

Gelified ethanol for percutaneous sclerotherapy of bone lesions: a systematic review of clinical applications and outcomes

Sylvain Grange, Laura-Cristina Morales Cifuentes, Rémi Grange, Nicolas Stacoffe, Maxime Pastor, Ibtisam Mahmoud, Hubert Marotte, Jean-Pierre Pelage, Natalia Gorelik

Skeletal Radiology · 2026-10 · 55 (10) · 2475-2483

DOI: 10.1007/s00256-026-05258-4 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Skeletal Radiology, online erschienen am 22.05.2026. Verfasst von Sylvain Grange und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Faculty of Medicine, University Hospital of Saint-Etienne, Saint-Etienne, France. grangesylvain@hotmail.fr. Hauptthemen laut MEDLINE: Bone Diseases, Bone Neoplasms, Ethanol, Sclerosing Solutions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To systematically review the available evidence on the feasibility, safety, and clinical effectiveness of percutaneous sclerotherapy using radiopaque gelified ethanol (RGE, Discogel®) for bone lesions. METHODS: A systematic search of MEDLINE, Embase, Web of Science, and Cochrane CENTRAL was performed. Primary studies reporting clinical, technical, and safety outcomes following RGE sclerotherapy for bone lesions were included. Data on patient characteristics, lesion type, procedural details, and outcomes were extracted and synthesized descriptively. RESULTS: Six retrospective studies involving 55 patients (mean age 22.2 ± 20.4 years; range 3-65; 26 females) with 56 lesions and 119 procedures were included (mean 2.16 procedures per patient). Aneurysmal bone cysts (80%) and aggressive vertebral hemangiomas (18%) were the main indications. Technical success was reported in 100% of procedures. Pain outcomes were available for 28 patients, with complete resolution in 64.3% (18/28), partial reduction in 32.1% (9/28), and persistence in 3.6% (1/28). Radiological follow-up (50 lesions) demonstrated complete response in 96% and partial response in 4%. No major adverse events were reported according to CIRSE (≥ 4) or CTCAE (≥ 4) criteria. One SIR grade 3 vertebral fracture occurred without confirmed causal association to RGE. Subsequent surgery was required in 3.6% of lesions. CONCLUSION: Although limited to small retrospective series, current evidence suggests that RGE sclerotherapy is a safe and effective minimally invasive option for selected benign bone lesions. Prospective comparative studies with longer follow-up are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone DiseasesBone NeoplasmsEthanolSclerosing SolutionsSclerotherapyHumansGelsTreatment Outcome

Stichwörter der Autor:innen

Bone neoplasmsBone sclerotherapyGelified ethanolMinimally invasive treatmentMusculoskeletal interventional radiologyPercutaneous ethanol injection

Substanzen

EthanolGelsSclerosing Solutions

Autor:innen und Institutionen

  • Department of Radiology, Faculty of Medicine, University Hospital of Saint-Etienne, Saint-Etienne, France. grangesylvain@hotmail.fr.
  • Jean Monnet University, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, Saint-Etienne, France. grangesylvain@hotmail.fr.
  • Department of Diagnostic Radiology, McGill University Health Centre (MUHC - Glen) - Royal Victoria Hospital, Montreal, Canada. grangesylvain@hotmail.fr.
  • Department of Diagnostic Radiology, McGill University Health Centre (MUHC - Glen) - Royal Victoria Hospital, Montreal, Canada.
  • Department of Radiology, Division of Neuroradiology, Hospital Universitario Fundación Santa Fe de Bogotá, Carrera 7 #117-15, Bogotá, Colombia.
  • Department of Radiology, Faculty of Medicine, University Hospital of Saint-Etienne, Saint-Etienne, France.

Zitieren

APA

Grange, S., Cifuentes, L. M., Grange, R., Stacoffe, N., Pastor, M., Mahmoud, I., Marotte, H., Pelage, J. P., & Gorelik, N. (2026). Gelified ethanol for percutaneous sclerotherapy of bone lesions: a systematic review of clinical applications and outcomes. Skeletal Radiology, 55(10), 2475-2483. https://doi.org/10.1007/s00256-026-05258-4

Vancouver

Grange S, Cifuentes LM, Grange R, Stacoffe N, Pastor M, Mahmoud I, et al. Gelified ethanol for percutaneous sclerotherapy of bone lesions: a systematic review of clinical applications and outcomes. Skeletal Radiology. 2026;55(10):2475-2483. doi:10.1007/s00256-026-05258-4

BibTeX
@article{Grange2026,
  author = {Grange, Sylvain and Cifuentes, Laura-Cristina Morales and Grange, Rémi and Stacoffe, Nicolas and Pastor, Maxime and Mahmoud, Ibtisam and Marotte, Hubert and Pelage, Jean-Pierre and Gorelik, Natalia},
  title = {Gelified ethanol for percutaneous sclerotherapy of bone lesions: a systematic review of clinical applications and outcomes},
  journal = {Skeletal Radiology},
  year = {2026},
  volume = {55},
  number = {10},
  pages = {2475--2483},
  doi = {10.1007/s00256-026-05258-4}
}
Kostenlos starten →